Doctors prescribing fewer antipsychotics for seniors after FDA warnings

Share this article:
Since the U.S. Food and Drug Administration put “black box” warnings on certain antipsychotics for seniors with dementia, doctors have been prescribing less of them, a new study found.

Researchers using data from Veterans Affairs registries found that overall use of older and newer antipsychotics dropped from 18% in 1999 to 12% in 2007, according to Reuters. Short of pulling it from the market, putting a black box warning on it is the strongest signal the FDA can send regarding the risks of a drug. Doctors in long-term care settings have been using drugs such as Seroquel and Risperdal with dementia patients exhibiting paranoia, aggression and agitation.

Researcher Dr. Helen C. Kales, a psychiatrist at the University of Michigan, said these drugs can still be beneficial to some patients, but added that simple changes, such as switching a patient from a female caregiver to a male caregiver, can ease symptoms, too. The study was published in the Feb. 7 issue of the Archives of General Psychology.
Share this article:

More in News

A small team of workers responds best in emergencies, expert says

A small team of workers responds best in ...

Long-term care providers should consider a "flat" crisis management approach that relies on a core group of staff members, experts advised Wednesday at the LeadingAge annual conference.

Nursing homes have better pain and catheter management if leaders have more ...

Nursing homes led by administrators and directors of nursing with higher levels of education and certification have better outcomes on some key quality measures, according to recently published findings.

Court green-lights charges that a healthcare network underused observation stays

A whistleblower can continue to pursue charges that a Nevada healthcare network routinely admitted people as hospital inpatients when they should have been placed in observation status, a federal appeals court recently ruled.